Enteric coated aspirin - does this reduce risk of bleeding complications?
- there is no evidence that using enteric coated or buffered formulations of aspirin provide less of a risk than the use of dispersible aspirin 75mg, which is an appropriate dosage form
Reference:
- MeReC Bulletin 2005; 15(6):21-4.
Related pages
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page